Beacon Pointe Advisors’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-600
Closed -$356K 1079
2023
Q1
$356K Buy
+600
New +$336K 0.01% 865
2022
Q4
Sell
-736
Closed -$432K 1061
2022
Q3
$432K Buy
736
+58
+9% +$34.7K 0.01% 684
2022
Q2
$370K Buy
678
+101
+18% +$51.1K 0.01% 752
2022
Q1
$366K Buy
577
+215
+59% +$111K 0.01% 911
2021
Q4
$245K Buy
+362
New +$220K 0.01% 805

Other funds holding AGL

Beacon Pointe Advisors's AGL Position: Q2 2023 in Review

Beacon Pointe Advisors sold out of Agilon Health (AGL) in Q2 2023, closing a stake of 600 shares — an estimated $356K sold.

Beacon Pointe Advisors first reported a position in AGL in Q4 2021 and held it in 5 quarters. The position peaked at $432K in Q3 2022. 185 funds tracked by Wall St. Rank hold AGL as of Q2 2023.

  • Beacon Pointe Advisors reported no remaining Agilon Health position as of Q2 2023 after selling out during the quarter.
  • Beacon Pointe Advisors sold 600 Agilon Health shares in Q2 2023, an estimated $356K.
  • Beacon Pointe Advisors first reported a position in Agilon Health in Q4 2021 and held it in 5 quarters.
  • Beacon Pointe Advisors's Agilon Health position peaked at $432K in Q3 2022.
  • 185 funds tracked by Wall St. Rank held Agilon Health as of Q2 2023.

Based on Beacon Pointe Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.